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ABSTRACT
Background and objective Risk-adjusted mortality
rates can be used as a quality indicator if it is assumed
that the discrepancy between predicted and actual
mortality can be attributed to the quality of healthcare
(ie, the model has attributional validity). The
Development And Validation of Risk-adjusted Outcomes
for Systems of emergency care (DAVROS) model predicts
7-day mortality in emergency medical admissions. We
aimed to test this assumption by evaluating the
attributional validity of the DAVROS risk-adjustment
model.
Methods We selected cases that had the greatest
discrepancy between observed mortality and predicted
probability of mortality from seven hospitals involved in
validation of the DAVROS risk-adjustment model.
Reviewers at each hospital assessed hospital records to
determine whether the discrepancy between predicted
and actual mortality could be explained by the
healthcare provided.
Results We received 232/280 (83%) completed review
forms relating to 179 unexpected deaths and 53
unexpected survivors. The healthcare system was judged
to have potentially contributed to 10/179 (8%) of the
unexpected deaths and 26/53 (49%) of the unexpected
survivors. Failure of the model to appropriately predict
risk was judged to be responsible for 135/179 (75%) of
the unexpected deaths and 2/53 (4%) of the unexpected
survivors. Some 10/53 (19%) of the unexpected
survivors died within a few months of the 7-day period
of model prediction.
Conclusions We found little evidence that deaths
occurring in patients with a low predicted mortality from
risk-adjustment could be attributed to the quality of
healthcare provided.
INTRODUCTION
The development of reliable and credible measures
to assess the performance of emergency care
systems is an important research priority.1
Mortality is an important outcome in emergency
care but differences in crude mortality may reﬂect
differences in case mix rather than quality of care.
Statistical models can be used to produce
risk-adjusted estimates of mortality that take differ-
ences in case mix into account.2 These can be used
to identify hospitals with high risk-adjusted mortal-
ity, with the inference that this reﬂects suboptimal
quality of care.3 This approach was notably used in
the UK to identify potential problems at the Mid
Staffordshire NHS Trust.
Risk-adjustment involves measuring patient char-
acteristics that are known to predict mortality and
then using these to predict a probability of death
for each patient treated by the emergency care
system. These probabilities can be summed across a
population to estimate the expected death rate for
the population overall which can then be compared
to the observed death rate. The ratio of the
observed to the expected death rate is typically
expressed as a standardised mortality ratio (SMR).
The UK Department of Health currently uses rou-
tinely available data to estimate a Summary
Hospital Mortality Index for each hospital in
England and Wales.4 The DAVROS study
(Development And Validation of Risk-adjusted
Outcomes for Systems of emergency care) showed
that the addition of physiological variables to
routine age and diagnostic data could improve pre-
diction and provide excellent discriminant value
for 7-day mortality across a range of settings.5
The use of risk-adjusted mortality rates as quality
indicators assumes that the discrepancy between
predicted and observed mortality is attributable to
the quality of care provided. If observed mortality
exceeds predicted mortality, then this discrepancy is
assumed to be due to poor care. Whether this
assumption is valid is an important but often
neglected aspect of the validation of
risk-adjustment methods. Attributional validity
refers to that aspect of validating a measure that
encompasses testing the assumption that changes
seen in the risk-adjusted outcome measure reﬂect
differences in care quality.2 6
We developed the DAVROS risk-adjustment
model to predict mortality in patients admitted to
hospital with a medical emergency and generate
estimates of risk-adjusted mortality for systems of
emergency care. The aim of this study was to evalu-
ate the attributional validity of the DAVROS model
in a variety of settings; in other words, to deter-
mine whether discrepancies between observed mor-
tality and mortality predicted by the DAVROS
model could be explained by the healthcare
provided.
METHODS
The methods for derivation and validation of the
DAVROS risk-adjustment model have been
described in detail elsewhere.5 The model was
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derived using data from 5644 patients admitted with a medical
emergency across three hospitals and then validated using data
from 13 762 patients across nine hospitals. The full model used
age, International Classiﬁcation of Disease (ICD-10) code,
known malignancy, physiological variables and routine blood
data to predict 7-day mortality. A more limited ‘physiology’
model was developed without the blood variables, which often
had high rates of missing data. The c-statistics for the full model
ranged from 0.83 to 0.93 across the validation centres, while
the c-statistics for the physiology model ranged from 0.80 to
0.91.
In previous studies, attributional validation has used explicit
or implicit review.2 6 Both involve investigators examining site-
level clinical and other material and then reaching a judgement
as to the quality of care being delivered. Explicit review involves
evaluation of cases against a predeﬁned list of quality criteria to
which the investigators refer, so they may literally ‘tick the box’
if they ﬁnd the criteria to be present. Implicit review relies on a
more general reviewer judgement of quality of care without spe-
ciﬁc criteria. The process of implicit review is therefore more
opaque than explicit review, but allows for more ﬂexibility in an
assessment as it is not limited to only predetermined items.
To evaluate the attributional validity of the DAVROS model
we used a method that was broadly an implicit review. The
review documentation and process allowed our reviewers
freedom to interpret and report circumstances as they saw ﬁt
with only minimal predetermination of categories, lists or cri-
teria. The study took place in seven hospitals in England,
Australia and Hong Kong that participated in the validation
phase of the DAVROS study. The research team selected a
number of cases (median 30 per hospital) on the basis of having
the greatest discrepancy between observed mortality and pre-
dicted probability of mortality. Thus, the review-set for each site
comprised cases where individuals had died, despite a very low
predicted probability of death, and cases where individuals had
survived, despite a very low predicted probability of survival.
The reviewer at each site was an experienced emergency phys-
ician who worked in the emergency department and acted as
investigator during the main data gathering phases of the
project. These clinicians reviewed the hospital records and, if
appropriate, the death certiﬁcate for each case, and identiﬁed
the factors that they believed signiﬁcant in explaining the dis-
crepancy between predicted and observed outcome. The clin-
ician reviewers were able to express an opinion as to why the
individual outcome was at variance with the original model
prediction.
The reviewer completed a form with six questions pertaining
to cases of unpredicted death (question set A) and four ques-
tions pertaining to cases of unexpected survival (question set B).
Question set A or B was completed depending on patient
outcome. No personal identiﬁers were recorded. The questions
on the reviewer form are shown in box 1.
Completed forms were mailed back to the research team and
data were entered into an Excel spreadsheet for analysis. The
responses to questions 2–5 were used to classify deaths as being
unexpected due to failure of the model or due to the healthcare
system. If question 4 or 5 identiﬁed an intervention that poten-
tially contributed to death or an intervention that was not given
but could have reasonably been expected to prevent death, then
death was classiﬁed as being due to failure of the healthcare
system. If not, the death was classiﬁed as being due to model
failure. Descriptive analysis was undertaken to present propor-
tions of cases (with 95% CI) attributable to the healthcare
system or aspects of the model.
The DAVROS study was approved by the Leeds East Research
Ethics Committee and relevant institutional ethics committees
in Australia and Hong Kong. The National Information
Governance Board (UK) also reviewed and approved the project
as it involved using patient identiﬁable data without consent.
However, in the phase of the project reported here, identiﬁable
patient data were only accessed by clinical staff from the rele-
vant hospital.
RESULTS
A total of 280 review forms were dispatched and 232 (83%)
were completed and returned. Table 1 shows the number of
forms dispatched and returned at each centre, and the SMR for
the centre estimated using the DAVROS model. If the SMR is
above 100, then observed mortality was higher than predicted.
Completion rates for individual centres varied from 68% to
95%. The reason for non-completion was not formally
recorded, but informally it appeared that the main reason was
failure to locate the hospital notes.
Table 2 summarises the responses relating to unexpected
deaths. The response is classiﬁed as true if answered ‘yes’ and
false if answered as ‘no’ or ‘unable to say’. The rows show the
combinations of responses and the tally gives the total number
of cases with each combination. We have excluded combinations
with a zero tally.
An intervention was identiﬁed that could have contributed to
death in 5/179 cases (rows 3 and 5) and an intervention was iden-
tiﬁed that could have been expected to prevent death in 10/179
cases (rows 1 and 6). Overall, therefore, unexpected deaths were
only potentially attributed to the healthcare system in 15/179
cases (8%; 95% CI 5% to 13%).
In 111/179 cases (rows 1 and 2) there was a potential mani-
festation of the cause of death in the model variables recorded
Box 1 Questions on the reviewer form
The questions on the form were as follows:
Section A (unexpected deaths)
Q1: What was the cause of death (from the death
certiﬁcate)?
Q2: Was there any potential manifestation of the cause of
death in the model variables recorded at presentation?
Q3: Was there any potential manifestation of the cause of
death in any presentation variable?
Q4: Did any intervention potentially contribute to death?
(Responses: yes; no; unable to say. If yes, text box provided
for additional comments)
Q5: Could any intervention have reasonably been expected to
prevent death? (Responses: yes; no; unable to say. If yes, text
box provided for additional comments)
Q6 Why did the patient die when the model predicted that
they would survive? (Free text)
Section B (unexpected survivors)
Q7: What was the reason for admission?
Q8: What was the cause of any abnormal physiological
variables in the model?
Q9: Did the patient receive a life-saving intervention?
(Responses: yes; no; unable to say. If yes, text box provided
for additional comments)
Q10: Why did the patient survive when the model predicted
that they would die?
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at presentation, suggesting that the model variables identiﬁed a
risk of death but may not have appropriately predicted the risk
of death in 62% (95% CI 55% to 69%) of cases. In 129/179
cases (rows 2 and 4) there was a potential manifestation of the
cause of death in any variable recorded at presentation, indicat-
ing that there was potential for presenting characteristics to
predict death in 72% (95% CI 65% to 78%). In 35 cases (20%;
95% CI 14% to 26%) there was no manifestation of the cause
of death at presentation and no intervention identiﬁed that
could have inﬂuenced survival, so these deaths appeared to be
unpredictable and unexplained.
Table 3 shows the interventions that were identiﬁed as having
potentially contributed to death or prevented death. The
reasons for failing to give an intervention were not usually
recorded, and in some cases it may have reﬂected a deliberate
decision to withhold an intervention on grounds of poor antici-
pated quality of life or respect for patient autonomy.
Free text responses were reviewed for common reasons for
failure of the model to predict a high risk of death. This sug-
gested that in patients with pneumonia, stroke or severe or mul-
tiple co-morbidities (eg, chronic obstructive pulmonary disease,
terminal cancer, renal failure, ischaemic heart disease) the
model often failed to predict a high risk of death that was
evident on examination of the full case record.
Table 4 compares the attributions between centres. The
purpose of this table is not to compare frequencies across the
centres (numbers are too small for such an analysis) but to dem-
onstrate that cases implicating the healthcare system are distribu-
ted across the centres.
Analysis of the 53 unexpected survivors showed that 26
received a potentially life-saving intervention and 27 did not.
The potentially life-saving interventions are shown in table 5.
Further information was provided for 17 of the 27 cases
where no potentially life-saving intervention was received to
explain why they survived when the model predicted they
would die. These are outlined in table 6. In most cases (10/17)
the patient died after the 7-day window of model prediction, so
the model correctly predicted death but not within 7 days.
Survival was attributed to response to treatment in three cases.
These may have been more appropriately classiﬁed as being
attributable to the healthcare system, but we analysed these
cases as they were classiﬁed by reviewers.
DISCUSSION
If risk-adjusted mortality rates are used to judge the quality of
healthcare, then the attributional validity of the risk-adjustment
model needs to be demonstrated.2 6 This may involve showing
Table 2 Categorisation of responses
Potential
manifestation
of the cause
of death in a
model
variable
Potential
manifestation
of the cause
of death in
any variable
Intervention
could have
contributed
to death
Intervention
could have
prevented
death Tally
Row 1 T T F T 6
Row 2 T T F F 105
Row 3 F T T F 2
Row 4 F T F F 24
Row 5 F F T F 3
Row 6 F F F T 4
Row 7 F F F F 35
Total 179
F, false; T, true.
Table 1 Completion rates for review forms
Centre SMR Total N in validation phase N cases selected N with forms completed Died Survived
A 88.1 (83.9 to 92.3) 2048 95 75 (79) 65 10
B 88.3 (83.8 to 92.8) 1515 37 35 (95) 27 8
C 99.0 (93.9 to 104.0) 1501 30 28 (93) 22 6
D 99.9 (94.2 to 105.5) 1434 34 26 (76) 19 7
E 111.7 (103.8 to 119.5) 1478 32 30 (94) 18 12
F 118.0 (111.5 to 124.5) 1592 31 21 (68) 15 6
G 124.1 (110.3 to 137.9) 1043 21 17 (81) 13 4
Total – – 280 232 179 53
SMR, standardised mortality ratio.
Table 3 Interventions that could have contributed to or prevented
death
Possibly contributing to death (Q4) Possibly preventing death (Q5)
Gastrointestinal bleed following
anticoagulant and antiplatelet treatment
for myocardial infarction
Thrombolytic therapy not given for
massive pulmonary embolism
Deterioration following percutaneous
pericardial drainage
No anticoagulant given for
pulmonary embolus and no
operation for peritonitis
Deterioration associated with high flow
oxygen in ambulance
Pacing wire not inserted for heart
block
Postoperative bronchopneumonia after
operation for fractured neck of femur
No prophylactic anticoagulation
given to prevent pulmonary
embolism
Delayed diagnosis of perforated
duodenal ulcer following steroid therapy
for chronic obstructive pulmonary
disease
Delayed diagnosis of dissecting
thoracic aneurysm
Emergency laparotomy not
performed for peritonitis
Patient refused antibiotics and blood
transfusion
No prophylactic anticoagulation
given to prevent pulmonary
embolism
Anticoagulation for atrial fibrillation
not given to prevent stroke
Thrombolytic therapy not given for
myocardial infarction
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that discrepancies between model prediction and actual
outcome are explained by the healthcare provided. In this
respect our analysis failed to demonstrate attributional validity
for unexpected deaths. Failure of the model to predict outcome
for those who died was often explained by failure of the model
variables to appropriately reﬂect the risk of death and only in a
minority of cases could failure of prediction be potentially
attributed to the healthcare provided.
Even when unexpected deaths could be attributed to the
healthcare provided, this may not have reﬂected suboptimal
care. We did not seek to determine the reasons why potentially
life-saving interventions were not used, but it is likely that in a
proportion of cases the intervention was deliberately withheld
out of respect for patient autonomy or as part of an end of life
care plan. There is a growing recognition that inappropriate
treatments and interventions are very costly to the health system
and confer very little beneﬁt to patients and families. This has
resulted in an emphasis on more appropriate end of life care
decided in discussion with patients and families. Increasingly,
these discussions and decisions are being initiated in emergency
departments.
Our ﬁndings concur with other studies that have struggled to
demonstrate the attributional validity of risk-adjusted mortality
for assessing the quality of hospital care.7–11 Most previous
studies have used explicit review methods to estimate quality of
care in terms of explicit standards of care and have evaluated
the correlation between quality and risk-adjusted mortality at an
institutional level. Our approach of evaluating discrepancies in
individual cases has not been widely used.
Evaluation of attributional validity is not often undertaken
and methods are poorly developed,2 6 so our inability to dem-
onstrate attributional validity may reﬂect limitations in our
methods rather than limitations of the model or the concept of
measuring risk-adjusted outcomes to assess quality. Risk predic-
tion inevitably involves a degree of random error and
imprecision. Failure of the model to predict outcome may
simply reﬂect this imprecision, particularly in the cases where
we identiﬁed no manifestation of the cause of death in any pre-
senting variable or any potential healthcare factor. Another limi-
tation is inherent to the review process, which can only capture
gross evidence of suboptimal healthcare. More subtle evidence
of suboptimal care, such as poor hygiene, poor nursing care or
inadequate monitoring, would not be apparent from case note
review. We were unable to review a proportion of cases due to
inability to retrieve case notes. This may be a source of bias as
there may be a speciﬁc reason why case notes are not available.
For example, if there is an enquiry into the healthcare provided,
notes may not be available.
A speciﬁc limitation of our methods was that the reviewers
were clinicians responsible for care in the hospitals they were
reviewing. When asked to review cases from their own institu-
tion, clinicians may interpret outcomes in the most favourable
or positive light. This may explain why healthcare interventions
were more frequently identiﬁed as explanations for unexpected
survival than unexpected death, and may mean that we have
underestimated the proportion of unexplained deaths that could
be attributed to healthcare intervention. It could also be argued
that the reviewer’s judgements may have been inﬂuenced by
their involvement in developing the DAVROS model study.
Table 4 Classification by centre, N (%)
Attribution
Centre
TotalA B C D E F G
Healthcare system 3 (5) 2 (8) 4 (18) 2 (11) 2 (12) 0 (0) 2 (16) 15
Model failure 59 (91) 9 (34) 16 (73) 13 (69) 15 (83) 10 (67) 7 (54) 129
Unpredictable death 3 (5) 16 (59) 2 (9) 4 (21) 1 (6) 5 (33) 4 (31) 35
Total 65 27 22 19 18 15 13 179
Table 5 Potentially life-saving interventions received by
unexpected survivors
Intervention
Number of times
cited
Intravenous fluids 11
Antibiotics 11
Intensive care, airway or respiratory support 5
Oxygen 3
Anticonvulsants 2
Steroids 2
Diuretic therapy 2
Blood transfusion, bronchodilators, vasodilators, insulin,
surgical procedure, temporary pacing wire
1× each
Table 6 Explanations identified for unexpected survival
Response to
treatment
Responded well to antibiotics and medical treatment
Successful medical treatment
Early access to consultant surgeon, well monitored,
intravenous fluids, antibiotics and insulin early on
Died after 7 days Responded to medical treatment but then died 2 weeks later
Care of dying pathway initiated, discharged to nursing home
where he died 2 weeks later
Dies on day 11
Died 12 days after admission
Died 8 days later
Died 9 days later
In hospital for 6 weeks and then died 4 months after
admission
In hospital for 4 months. Subsequently died 2 months after
discharge
Patient died 2 months later
Responded to medical treatment. Subsequently died
3 months after admission
Unclear Unclear. Limited therapy instituted consisting of oxygen,
antibiotics and fluids
Unclear. Limited treatment given with agreement of family
Poor model
prediction
Model prediction of death based on relatively minor
derangements of blood variables
Variables in the model altered by his particular presentation
(infective exacerbation of chronic obstructive pulmonary
disease) and hence the likelihood of death ‘overstated’
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Employing external reviewers, not connected with the institu-
tion, would have provided a greater degree of impartiality.
However, data protection legislation presents barriers to those
from outside the care team accessing notes. Obtaining consent
or anonymisation of notes is unlikely to be feasible. Even if data
protection barriers can be overcome, the process of independent
external review may be prohibitively expensive. Alternatively we
could have used an explicit review process in which our
reviewer evaluated cases against a predeﬁned list of quality cri-
teria. This could have reduced the potential for reviewers to
make biased judgements but would have limited their ability to
identify issues that were not predeﬁned. We chose to use an
implicit review process because the potential range of judge-
ments that would need to be predeﬁned for an explicit review
process would have been substantial and unwieldy, and yet
might still not have covered key issues.
Although failure to demonstrate attributional validity under-
mines the use of risk-adjusted mortality as a quality indicator, it
does not mean that risk-adjusted data are worthless. This study
identiﬁed a number of cases where healthcare was potentially
suboptimal and could form the basis for more detailed investiga-
tion. Risk-adjustment can provide a means of identifying cases
with the greatest discrepancy between predicted and actual
outcome, where detailed audit would be most worthwhile. This
use of risk-adjustment could be enhanced by further research.
For example, this study identiﬁed presentation variables that are
not currently included in the model, such as ECG abnormalities,
that could improve model prediction. In conclusion, however,
this study found little evidence that deaths occurring in patients
with a low predicted mortality from risk-adjustment could be
attributed to the quality of healthcare provided.
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